Genome-Wide Profiling of REST/NRSF Targets in Adult Neural Stem Cells

成体神经干细胞 REST/NRSF 靶标的全基因组分析

基本信息

  • 批准号:
    8274637
  • 负责人:
  • 金额:
    $ 19.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-06-06 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): An essential guardian of the neuronal genome is the transcriptional repressor REST/NRSF. The long-term goal is to better understand the transcriptional and epigenetic circuitry important for neuronal cell fate, in both physiological and pathological contexts. The objective of this grant proposal is to generate a genome-wide view of REST/NRSF target genes by performing ChIP-Seq and RNA-seq in adult neural stem cells. The central hypothesis is REST/NRSF is essential for stem cell quiescence and is a master negative regulator of adult hippocampal neurogenesis. The rationale for the proposed research is that understanding developmental mechanisms controlling the neuronal lineage program have the potential to further therapeutic approaches to an increasing number of mental disorders linked to neuronal loss or aberrant neuronal function. Thus, the proposed study is relevant to that part of NIH's mission that relates to gaining fundamental knowledge that will potentially help treat neurological disorders. Guided by strong preliminary data, this hypothesis will be tested by pursuing two specific aims: 1) Genome-wide identification of REST/NRSF targets in adult NSC chromatin and 2) Transcriptome analysis of adult NSCs during quiescence, proliferation, and neuronal differentiation. Aim 1 will focus on performing ChIP-Seq of REST/NRSF in adult hippocampal neural stem cells. Aim 2 will focus on performing RNA-seq from adult NSCs under conditions of quiescence, proliferation, and neuronal differentiation. Aim 2 will also identify which targets are dependent on REST/NRSF by comparing ChIP-Seq targets to gene expression analysis from REST/NRSF conditional knockout mice generated in our laboratory. The conceptual framework and approach is innovative, because it is the first study to apply state-of-the-art deep sequencing techniques to a physiologically relevant adult neural stem cell system in order to identify a genome-wide view of REST/NRSF target genes. The proposed R21 grant is significant, because it is expected to advance and expand our basic understanding of transcriptional networks regulating stem cell quiescence, proliferation, and neuronal differentiation which may be of particular importance for restoring cognitive function after brain damage or disease.
描述(由申请人提供):神经元基因组的一个重要监护人是转录抑制因子REST/NRSF。长期目标是更好地了解在生理和病理背景下对神经元细胞命运重要的转录和表观遗传电路。这项资助提案的目的是通过在成人神经干细胞中进行ChIP-Seq和RNA-seq来产生REST/NRSF靶基因的全基因组视图。中心假设是REST/NRSF是干细胞静止所必需的,并且是成年海马神经发生的主要负调节因子。拟议研究的基本原理是,了解控制神经元谱系程序的发育机制有可能进一步治疗越来越多的与神经元丢失或异常神经元功能相关的精神障碍。因此,拟议的研究与NIH的使命的一部分有关,即获得可能有助于治疗神经系统疾病的基础知识。 在强有力的初步数据的指导下,该假设将通过追求两个特定目标进行测试:1)成人NSC染色质中REST/NRSF靶标的全基因组鉴定和2)静止、增殖和神经元分化期间成人NSC的转录组分析。目的1将致力于在成年海马神经干细胞中进行REST/NRSF的ChIP-Seq。目标2将专注于在静止、增殖和神经元分化的条件下从成年NSC执行RNA-seq。目标2还将通过比较ChIP-Seq靶标与我们实验室产生的REST/NRSF条件性敲除小鼠的基因表达分析来确定哪些靶标依赖于REST/NRSF。概念框架和方法是创新的,因为它是第一个将最先进的深度测序技术应用于生理相关的成人神经干细胞系统的研究,以确定REST/NRSF靶基因的全基因组视图。拟议的R21赠款意义重大,因为它有望推进和扩大我们对调节干细胞静止、增殖和神经元分化的转录网络的基本理解,这可能对脑损伤或疾病后恢复认知功能特别重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jenny Hsieh其他文献

Jenny Hsieh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jenny Hsieh', 18)}}的其他基金

Molecular control of aberrant adult-born granule cells in epilepsy
癫痫中异常成年颗粒细胞的分子控制
  • 批准号:
    10737298
  • 财政年份:
    2023
  • 资助金额:
    $ 19.86万
  • 项目类别:
ApoE4 in human cortical interneuron degeneration and network activity
ApoE4 在人类皮质中间神经元变性和网络活动中的作用
  • 批准号:
    9916999
  • 财政年份:
    2020
  • 资助金额:
    $ 19.86万
  • 项目类别:
Targeting aberrant neurogenesis to prevent epilepsy and associated cognitive decline
针对异常的神经发生来预防癫痫和相关的认知能力下降
  • 批准号:
    9247257
  • 财政年份:
    2016
  • 资助金额:
    $ 19.86万
  • 项目类别:
Targeting aberrant neurogenesis to prevent epilepsy and associated cognitive decline
针对异常的神经发生来预防癫痫和相关的认知能力下降
  • 批准号:
    9127529
  • 财政年份:
    2016
  • 资助金额:
    $ 19.86万
  • 项目类别:
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts
生理和病理背景下成人神经发生的新机制
  • 批准号:
    8492002
  • 财政年份:
    2012
  • 资助金额:
    $ 19.86万
  • 项目类别:
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts
生理和病理背景下成人神经发生的新机制
  • 批准号:
    8851478
  • 财政年份:
    2012
  • 资助金额:
    $ 19.86万
  • 项目类别:
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts
生理和病理背景下成人神经发生的新机制
  • 批准号:
    8281205
  • 财政年份:
    2012
  • 资助金额:
    $ 19.86万
  • 项目类别:
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts
生理和病理背景下成人神经发生的新机制
  • 批准号:
    9087084
  • 财政年份:
    2012
  • 资助金额:
    $ 19.86万
  • 项目类别:
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts
生理和病理背景下成人神经发生的新机制
  • 批准号:
    8719897
  • 财政年份:
    2012
  • 资助金额:
    $ 19.86万
  • 项目类别:
Genome-Wide Profiling of REST/NRSF Targets in Adult Neural Stem Cells
成体神经干细胞 REST/NRSF 靶标的全基因组分析
  • 批准号:
    8179569
  • 财政年份:
    2011
  • 资助金额:
    $ 19.86万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了